Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Histamine Release and Implications of H1- and H2-Blockade in Adult Cardiac Surgery - A Randomised Controlled Study
ISRCTN ISRCTN28343638
ClinicalTrials.gov identifier
Public title Histamine Release and Implications of H1- and H2-Blockade in Adult Cardiac Surgery - A Randomised Controlled Study
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis Systemic inflammatory response is associated with cardiac surgery. Mediators liberated include cytokines and histamine. Histamine is associated with systemic effects like vasodilatation and cardiac dysrhythmias.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cardiovascular disease
Participants - inclusion criteria Entry criteria: Patients presenting for elective coronary artery bypass grafting (CABG) and valve surgeries using cardiopulmonary bypass.
Participants - exclusion criteria 1. Patients on heparin or nitrate infusions
2. Patients with known allergies
3. Known asthmatics and patients with severe chronic obstructive pulmonary disease (COPD)
4. Patients on steroids or other immunosuppressive drugs
5. Emergency procedures or re-do operations
6. Patients on regular H1 or H2 blockers
Anticipated start date 01/02/2005
Anticipated end date 01/01/2006
Status of trial Completed
Patient information material
Target number of participants 80
Interventions Patients will be randomly allocated into two groups.
Group H: this group will receive prophylactic H1- and H2-blockade
Group O: control group with no H1- and H2-blockade (placebo)
The study will be double blinded.
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding University of Wales College of Medicine (UWCM) Endowment Fund, UK
Trial website
Publications
Contact name Dr  Cristina  Diaz-Navarro
  Address University Hospital of Wales
  City/town Cardiff
  Zip/Postcode CF4 4XW
  Country United Kingdom
  Tel +44 (0)2920743107
  Email
Sponsor University of Wales College of Medicine, UK
  Address Heath Park
  City/town Cardiff
  Zip/Postcode CF4 4XW
  Country United Kingdom
  Email HumphreysJM@cf.ac.uk
Date applied 15/12/2004
Last edited 31/05/2011
Date ISRCTN assigned 31/01/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central